✨ Your Portfolio is fetched and updated from zerodha.
Nano
Market Cap
₹252 Cr.
P/E
13.36

Key Ratios

Market cap
Market cap
252 Cr
PE
PE
13.36
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
11.94
ROCE (%)
ROCE (%)
12.78
Div Yield (%)
Div Yield (%)
-
Sales
Sales
297 Cr
OPM (%)
OPM (%)
10.51 %
Debt to Equity
Debt to Equity
-
About
Balaxi Pharma. is in the Miscellaneous sector with a M.cap of 252.00 Cr and a PE ratio… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Balaxi Pharmaceuticals Ltd. Business

Balaxi Ventures Limited is a listed company managing procurement, production, supply chain, distribution, and point of sale for pharmaceutical, food products, and builders hardware through international wholesale trading.

Balaxi Pharma. major competitors are Ambalal Sarabhai Ent, Gennex Lab, Vaidya Sane Ayur Lab, Alpa Lab, Panchsheel Organics, Medico Remedies, Kimia Biosciences.
Market Cap of Balaxi Pharma. is ₹253 Crs.
While the median market cap of its peers are ₹239 Crs.

Balaxi Pharma. seems to be less financially stable compared to its competitors.
Altman Z score of Balaxi Pharma. is 4.87 and is ranked 6 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun
Investor Presentation Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Sep
Conference Call Jun Sep
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material